James Edward Bass, Director at REATA PHARMACEUTICALS INC (RETA), bought 8,064 shares at $31.00 ($250K) on 2017-08-01, disclosed to the SEC on 2017-08-01.
Open-market purchase of $250k RETA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| RETA | BUY | 2018-11-19 | $199K | — | Filing → |
| RETA | BUY | 2018-07-26 | $139K | — | Filing → |
| RETA | BUY | 2017-11-16 | $187K | — | Filing → |